U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Cytokinetics and Pluristem Therapeutics

Continue Reading

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

RDInvesting Provides Stocks Research on United Therapeutics and Viropharma

Continue Reading

DirectCash Payments Inc. Announces Regular Cash Dividend

CALGARY, ALBERTA -- (Marketwire) -- 02/15/13 -- DirectCash Payments Inc. (the "Company" or "DirectCash") (TSX: DCI)…

Continue Reading

TODAY-BMO Panel: How to Create a Winning RRSP Portfolio

Join BMO investing experts on February 15th at 11 a.m. as they provide insights on how…

Continue Reading

The Tax Institute at H&R Block Announces Event Series Examining Real-World Implications of Health Care Reform

H&R Block to Bring Together Policymakers, Health Care and Tax Experts to Discuss the Enrollment for…

Continue Reading

Vantage FX UK Opens the Door for Ambitious Forex Traders

LONDON, UNITED KINGDOM -- (Marketwire) -- 02/15/13 -- -Introducing Brokers- is an exciting proposition for ambitious…

Continue Reading

DLA Activates Authentication Contract With Applied DNA Sciences

Supports Mandate by Agency for Use of SigNature(R) DNA on Electronics

Continue Reading

Brookfield Residential Completes 2012 Annual Filings

CALGARY, ALBERTA -- (Marketwire) -- 02/14/13 -- Investors, analysts and other interested parties can access Brookfield…

Continue Reading

Franklin Universal Trust Declares Monthly Dividend

SAN MATEO, CA -- (Marketwire) -- 02/14/13 -- Franklin Universal Trust (NYSE: FT), a closed-end investment…

Continue Reading

Franklin Templeton Limited Duration Income Trust Declares Monthly Dividend

SAN MATEO, CA -- (Marketwire) -- 02/14/13 -- Franklin Templeton Limited Duration Income Trust (NYSE MKT:…

Continue Reading